Global Clinical Chemistry Analyzer Market: Overview
Clinical chemistry analyzers are the computer-programmed devices utilized for determining and analyzing the levels of sugar and protein present in the blood. These devices within the least possible time come up with an accurate result as they have extremely advanced technologies and are designed for such purpose. Clinical chemistry tests are carried out to verify clinical conditions such as kidney function, nutritional state, and liver function. Also, the tests are generally implemented to investigate clinical situations, including diabetes, arteriosclerosis, and hyperlipidemia.
Global Clinical Chemistry Analyzer Market: Growth Factors
The prominent factors contributing to the growth of global clinical chemistry analyzer market are the growing health care expenditure, fast growth in the diagnostic market, and rising prevalence rates of lifestyle disease, including diabetes and obesity. Furthermore, the rising elderly population, increasing need for laboratory automation, and increasing alertness for preventive healthcare are few other factors that are fueling the growth of the market. On the other hand, the high cost, the risk of outcome ambiguity, and the need of trained and qualified professionals are few of the factors that may impede market growth.
Global Clinical Chemistry Analyzer Market: Segmentation
The global clinical chemistry analyzer market can be segmented based on the test, product, end-user, and region. The test segment of the market is divided into the renal profile, electrolyte panel, lipid profile, specialty chemicals, basic metabolic panel, thyroid function panel, and liver panel. The product segment of the market is diversified into reagents, analyzers, and other products. The reagent segment of the clinical chemistry analyzer market is sub-segmented into controls, calibrators, standards, and others reagents. The analyzers segment of the market is sub-divided into very large (2000 Tests/H), large (1200-2000 Tests/H), medium (800-1200 Tests/H), and small (400-800 Test/H). The end-user segment of the market is categorized into diagnostics laboratories, academic research institutes, hospitals, and other end users. Regionally, the global clinical chemistry analyzer market is classified into Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa.
Global Clinical Chemistry Analyzer Market: Regional Analysis
North America is anticipated to dominate the market for clinical chemistry analyzer in the coming period owing to the high affordability of the consumers, the existence of enhanced technology, and vigorous healthcare infrastructure. Asia-Pacific region is also expected to grow in the market at a significant rate in the coming period due to the growing need for automation, the increasing economic conditions, and the rising patient alertness for preventive care in this region.
Global Clinical Chemistry Analyzer Market: Competitive Players
The prominent players in the global clinical chemistry analyzer include Mindray Medical International Limited, Danaher Corporation, Siemens AG, Roche Diagnostics, and Abbott Diagnostics. The other major players in the market are Ortho-Clinical Diagnostics, ElitechGroup, Thermo Fisher Scientific, Randox Laboratories Ltd., and Horiba.
Global Clinical Chemistry Analyzer Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
What Report Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
